Benoit Rousseau: Editorial on the prognostication of stage III colon cancer with Andrea Cercek
Benoit Rousseau, Assistant Attending Physician and Assistant Lab Member at Memorial Sloan Kettering Cancer Center, shared a LinkedIn post about recent editorial he authored with Andrea Cercek:
“Check out our editorial on the prognostication of stage III colon cancer with Andrea Cercek!
We comment the recent article by Gallois et al. introducing the idea of multidimensional prognosis assessment integrating clinical, pathological results along with ctDNA and incorporating information about tumoral microenvironment and stromal features.
The optimal assessment is currently fragmented in silos, and I believe that we need to combine multiple parameters and methods for optimal assessment. No convenient technology allows this in a single assay so far, and it is likely the future!
This multidimensional assessment will allow to individualize treatment, from skipping adjuvant therapy for very low risk patients, to modulating the duration of chemotherapy or propose adjuvant therapy intensification to improve outcomes. Patients need it urgently!”
Authors: Benoit Rousseau and Andrea Cercek
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023